期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 294, 期 1-2, 页码 95-101出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2010.03.022
关键词
Amyotrophic lateral sclerosis (ALS); Motor neuron disease (MND); Muscle atrophy; Neuronal nitric oxide synthase (nNOS); Superoxide dismutase (SOD1)
资金
- Nervous and Mental disorders [20B-13]
- Research on Measures for Intractable Diseases
- Japanese Ministry of Health Labor and Welfare [19590977, 21591070]
- Japanese Ministry of Education, Culture, Sports, Science and Technology [19890016]
- Grants-in-Aid for Scientific Research [21591070, 19890016, 19590977] Funding Source: KAKEN
Previously, we demonstrated that neuronal nitric oxide synthase (nNOS) is activated and promotes muscle atrophy in skeletal muscle during tail suspension, a model of unloading and denervation. Here, we examined patients with amyotrophic lateral sclerosis (ALS) and mutant (H46R) SOD1 transgenic (Tg) mice model using immunohistochemistry, Western blotting and real time PCR. We found cytoplasmic nNOS staining of angulated muscle fibers in patients with ALS. We also examined mutant SOD1 Tg mice and found cytoplasmic nNOS staining even before the onset of clinical muscle atrophy. In the Tg mice, nNOS was largely extracted with 100 mM NaCl and barely detected in the pellet fraction, suggesting fragile anchoring of nNOS to the sarcolemma. We also showed an elevated expression of atrogin-1, key molecules in muscle atrophy at the end stage. A common nNOS dislocation/atrogin-1/muscle atrophy pathway among tail suspension, denervation and ALS is suggested. nNOS modulation therapy may be beneficial in several types of muscle atrophy. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据